Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 11, Special Issue 11 (2022)

Clinical, haemato-biochemical and oxidative changes associated with chronic kidney disease (CKD) in dogs

Author(s):
Ritu Gupta, Geeta Rani Jena, Biswa Ranjan Jena, Ramesh Chandra Patra and Dhirendra Kumar
Abstract:
Chronic kidney disease (CKD) is a commonly encountered problem in canine practice and associated with significant haematological and biochemical abnormalities. The aim of this investigation was to identify the clinical signs, haemato-biochemical and oxidative alterations in dogs affected with chronic kidney disease. Twenty-two dogs affected with CKD were evaluated. All affected animals had microcytic hypochromic and non-regenerative anaemia. Haemoglobin (7.96±0.33g/dl), PCV (26.58±5.8%), TEC (4.39±0.16 x106 cells/µl) and platelet count (112±8.62 x103 cells/µl) were reduced significantly in CKD patients as compared to healthy animals. TLC count and neutrophil percentage were significantly increased in affected dogs. Serum creatinine (7.52±1.09 mg/dl) and BUN level (286.35±35.16 mg/dl) was increased significantly, whereas, serum total protein and albumin level were decreased, but statistically non-significant. Serum electrolyte estimation revealed hyperphosphatemia (6.99±0.04 mg/dl), hyperkalaemia, hyponatremia, and hypocalcaemia. There was a significant reduction in catalase, SOD, and GSH level and increase in LPO level (7.99±0.37 nmol MDA/mg of Hb) indicating severe oxidative injury to tissues and RBCs, and associated with severity of the disease. In conclusion, these serum and haematological markers provided important information regarding pathogenesis and disease progression of CKD, and should be evaluated in these patients while adopting appropriate treatment protocol
Pages: 1575-1579  |  244 Views  153 Downloads
How to cite this article:
Ritu Gupta, Geeta Rani Jena, Biswa Ranjan Jena, Ramesh Chandra Patra and Dhirendra Kumar. Clinical, haemato-biochemical and oxidative changes associated with chronic kidney disease (CKD) in dogs. The Pharma Innovation Journal. 2022; 11(11S): 1575-1579.

Call for book chapter